Dr. Keisuke Ito is an Associate Professor of Cell Biology and Medicine, the Director of Scientific Resources of the Stem Cell Institute, and Director of the Single Cell Genomics Core at the Albert Einstein College of Medicine. He obtained his M.D. and Ph.D. at the School of Medicine at Keio University, Japan, where he also acquired clinical experience in hematology-oncology at Keio University Hospital. He has an extensive background in hematology, oncology, myelodysplastic syndrome (MDS) pathogenesis, stem cell biology, mitochondrial physiology, and stem cell aging, having published 47 peer-reviewed articles (+30 invited publications) in high-impact journals such as Nature, Science, Cell Stem Cell, Cell Reports, and EMBO Reports. The central research goal of the Ito Lab is to shed light on the pathways controlling the equilibrium of healthy and malignant hematopoietic stem cells as a first step toward developing therapies to eradicate blood cancer cells and eventually cure MDS.